Gr Sarantis (SAR) H1 2025 earnings summary

Executive summary

• Strategy execution remains consistent, focusing on core categories, digital transformation, and international expansion, especially in Beauty, Skin Care, and Sun Care.

• Integration of Stella Pack is nearly complete, supporting supply chain, regeneration capabilities, and operational efficiency.

• Major CapEx investments in digital transformation, manufacturing upgrades, and sustainability initiatives are on track.

• Commercial excellence, innovation, and targeted promotion optimization are key focus areas.

• Consolidated sales for H1 2025 reached €304.3 million, up 0.5% year-over-year, with strong growth in Greece and a decline in some international markets due to currency effects and portfolio rationalization.

Financial highlights

• H1 2025 net sales reached €304.3 million, up 0.5% year-over-year.

• EBITDA increased by 15.7% to €48.3 million; EBITDA margin rose to 15.9%.

• EBIT up 18% to €37.5 million; EBIT margin at 12.3%, up 181 bps.

• Net profit rose 20% to €29.2 million; EPS up 22.2% to €0.4575.

• Free cash flow generation of €13.4 million; net debt reduced to €32.8 million as of June 30, 2025.

Outlook and guidance

• 2025 guidance: EBITDA €92 million (+12.7% vs 2024), EBIT €70 million (+14.8% vs 2024), net sales €612 million (+2% vs 2024).

• Five-year plan targets 4.5–5% organic growth annually and doubling EBITDA by 2028.

• Strategic priorities include market consolidation, operational optimization, and investment in digital tools.

• No change to medium-term sales or margin guidance; maintaining focus on organic growth and profitability.